Advertisement
The Leading Source for Pharmaceutical & Biopharmaceutical Manufacturing News
Subscribe to Pharmaceutical Processing
View Sample

FREE Daily Email Newsletter

More Children Live to Age 5, Work Still to be Done

September 16, 2014 8:28 am | by LAURAN NEERGAARD, AP Medical Writer | News | Comments

More of the world's children are surviving to their fifth birthday, but 6.3 million still died last year, mostly from preventable causes, the U.N. children's agency said Tuesday. That's nearly 17,000 young children dying every day.   

TOPICS:

US to Assign 3,000 from US Military to Fight Ebola

September 16, 2014 8:25 am | by JIM KUHNHENN, Associated Press | News | Comments

The Obama administration is ramping up its response to West Africa's Ebola crisis, preparing to assign 3,000 U.S. military personnel to the afflicted region to supply medical and logistical support to overwhelmed local health care systems and to boost the number of beds needed to isolate and treat victims of the epidemic.

TOPICS:

Allergan Agrees to Move Forward with Meeting

September 16, 2014 6:44 am | by The Associated Press | News | Comments

Allergan and Pershing Square are agreeing on at least one step toward settling a fight over the makeup of the Botox-maker's board. Allergan will hold special shareholders meeting, as Pershing Square and its partner, Valeant Pharmaceuticals, continue their push for control of the drugmaker.

TOPICS:
Advertisement

NY Files Alzheimer's Drug Lawsuit

September 15, 2014 7:42 pm | by Michael Virtanen - Associated Press - Associated Press | News | Comments

New York's attorney general filed a federal lawsuit Monday seeking to stop a manufacturer from discontinuing its drug widely used to treat Alzheimer's patients, arguing the company is illegally driving patients to its newer patented drug to avoid losses from cheaper generic alternatives coming out next year.

TOPICS:

Avanir Pharma Soars on Agitation Drug Study

September 15, 2014 3:46 pm | by The Associated Press | News | Comments

Shares of Avanir Pharmaceuticals soared Monday after the company reported positive clinical trial results for a drug that is designed to treat agitation in Alzheimer's disease patients. The company said patients who were treated with AVP-923 were less agitated than patients given a placebo.

TOPICS:

Purge System

September 15, 2014 11:53 am | by Nikita Ernst, Associate Editor | Product Releases | Comments

Introducing the latest addition to the Bebco EPS line of proven purge solutions, the 5500 series purge and pressurization system.

Respiratory Virus Cases Reported in More States

September 15, 2014 9:05 am | Videos | Comments

The potentially deadly enterovirus D-68 presents danger to young children.                              

TOPICS:

Millions of Antibiotic Prescriptions for Kids May Be Unnecessary, Study Finds

September 15, 2014 8:56 am | Videos | Comments

Pediatric researchers found that 11 million prescriptions for antibiotics in kids may be unnecessary.                         

TOPICS:
Advertisement

Skin Shocks Used at Massachusetts School Draw FDA Scrutiny

September 15, 2014 8:44 am | by JENNIFER C. KERR, Associated Press; LAURAN NEERGAARD, Associated Press | News | Comments

The Food and Drug Administration is considering whether to ban devices used by the Judge Rotenberg Educational Center in Canton, Massachusetts, the only place in the country known to use skin shocks as aversive conditioning for aggressive patients.

TOPICS:

Hurdles for Obama Health Law in Second Sign-Up Season

September 15, 2014 8:39 am | by RICARDO ALONSO-ZALDIVAR, Associated Press | News | Comments

Potential complications await consumers as President Barack Obama's health care law approaches its second open enrollment season, just two months away. Don't expect a repeat of last year's website meltdown, but the new sign-up period could expose underlying problems with the law itself that are less easily fixed than a computer system.

TOPICS:

FDA Approves Baxter’s HYQVIA for Treatment of Adults with Primary Immunodeficiency

September 15, 2014 8:31 am | News | Comments

Baxter International and Halozyme Therapeutics announced that the FDA approved Baxter’s subcutaneous treatment for adult patients with primary immunodeficiency (PI), HYQVIA [Immune Globulin Infusion 10% (Human) with Recombinant Human Hyaluronidase].

TOPICS:

Anti-Addiction Medicine Linked to Poisonings

September 15, 2014 8:27 am | by LINDSEY TANNER, AP Medical Writer | News | Comments

An anti-addiction drug used to fight the nation's heroin and painkiller abuse epidemics poses a threat to young children who accidentally swallow relatives' prescriptions, a federal study says. Some children have died.      

TOPICS:

U.S. Government, WHO Seek Ways to Expand Production of Ebola Drugs, Vaccines

September 15, 2014 8:20 am | by Helen Branswell, The Canadian Press | News | Comments

High level efforts are underway to find ways to substantially ramp up production of experimental Ebola vaccines and drugs, officials at the World Health Organization and within the U.S. government say.         

TOPICS:

FDA Accepts Tuzistra XR NDA for Full Review

September 15, 2014 8:12 am | News | Comments

Vernalis and Tris Pharma announced that the FDA has confirmed that the New Drug Application for Tuzistra XR has been accepted for full review. This triggers a milestone payment from Vernalis to Tris.        

TOPICS:

Gilead to License Generic Version of Sovaldi

September 15, 2014 8:07 am | by The Associated Press | News | Comments

Gilead Sciences says it has reached a deal with several generic drugmakers to produce cheaper versions of its popular, expensive hepatitis C drug Sovaldi for use in developing countries.           

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading